Multichannel
Digital patient engagement finalists revealed
Cell and gene therapy: how to discover and communicate clinical worth
CGTs are often expensive, and the healthcare sector is increasingly working on a tight budget. To bolster CGT market access potential, pharm...
What not to miss on Cell and Gene Therapy stage at Reuters Events: Pharma USA 2024
From building a solid value proposition to innovating through collaboration, discover where industry changemakers see the strengths of cell ...
Cell and gene therapy: ways to generate evidence to demonstrate value
Although cell and gene therapies (CGTs) are typically expensive products, there are techniques that pharmaceutical companies can execute to ...
How pharma is empowering key account managers to serve a changing customer base
Key account management (KAM) has become increasingly important to pharma companies as payers and other stakeholders have begun to exert more...